CRON vs TLRY · P/E 14, rev $98.2M vs rev $915.5M
Cronos Group Inc (CRON) versus Tilray Inc (TLRY) — a side-by-side from cached financials, not a winner call.
Cronos Group Inc (CRON) is a drug manufacturers - specialty & generic company listed on US.
Tilray Inc (TLRY) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported CRON revenue for 2026-06-30 was $98.2M. Net income was $45.8M. CRON currently screens at market cap $738.3M and trailing P/E 13.6.
Latest reported TLRY revenue for 2026-05-31 was $915.5M. Net income was -$121.4M. Revenue was up 11.5% from 2025-05-31 to 2026-05-31. TLRY currently screens at market cap $573.9M.
CRON currently screens at market cap $738.3M and trailing P/E 13.6. TLRY currently screens at market cap $573.9M.
Not investment advice. Open the CRON and TLRY stock pages for the full models.
Not investment advice.